Nelile Gwentshu

An All-Oral 6-Month Regimen for Multidrug-Resistant TB (the NExT Study): A Multicenter, Randomized Controlled Trial.

G. Maartens, K. Dheda, A. Pooran, 2022, American journal of respiratory and critical care medicine.